Therefore, focusing on the development of agents that block the OPG protein from acting as a decoy receptor for the TRAIL receptor, and therefore disrupt the binding of OPG to TRAIL, can allow TRAIL to induce apoptosis in breast cancer cells effectively [27]. This evidence concerns the gene TNFRSF11B and breast carcinoma.